Alan G. Dawson
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways.
Journal: Genes, chromosomes & cancer
Published: May 03, 2023
Corrigendum to 'True thymic hyperplasia causing pure red cell aplasia: a case report'.
Journal: Interactive cardiovascular and thoracic surgery
Published: January 13, 2022
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 05, 2021
True thymic hyperplasia causing pure red cell aplasia: a case report.
Journal: Interactive cardiovascular and thoracic surgery
Published: July 27, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: June 08, 2021
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.
Journal: British journal of cancer
Published: April 18, 2021
Metastatic renal cell carcinoma extending to the left atrium through the inferior pulmonary vein.
Journal: Interactive cardiovascular and thoracic surgery
Published: November 01, 2020
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
Journal: Scientific reports
Published: September 21, 2020
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: September 18, 2020
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial.
Journal: The Lancet. Respiratory medicine
Published: June 02, 2020
Last Updated: 09/26/2026